Immunogenic Stimulus for Germline Precursors of Antibodies that Engage the Influenza Hemagglutinin Receptor-Binding Site

Cell Reports

Volumn 13, Issue 12, 2015, Pages 2842-2850

  Schmidt, Aaron G ^a   Do, Khoi T ^a   McCarthy, Kevin R ^a   Kepler, Thomas B ^b   Liao, Hua Xin ^c   Moody, M Anthony ^c   Haynes, Barton F ^c   Harrison, Stephen C ^a,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; INFLUENZA VACCINE; INFLUENZA VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODY; VIRUS ANTIGEN; VIRUS HEMAGGLUTININ; H1N1 VIRUS HEMAGGLUTININ; PROTEIN BINDING;

ANTIBODY RESPONSE; ANTIBODY STRUCTURE; ANTIGEN BINDING; ANTIGENICITY; ARTICLE; B LYMPHOCYTE; BINDING AFFINITY; BINDING SITE; HUMORAL IMMUNITY; IMMUNE EVASION; IMMUNOLOGICAL MEMORY; IMMUNOSTIMULATION; INFANCY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SEASONAL VARIATION; UNMUTATED COMMON ANCESTOR; VIRUS ATTACHMENT; VIRUS IMMUNITY; VIRUS RESISTANCE; ANTIBODY PRODUCTION; BIOSYNTHESIS; HEK293 CELL LINE; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1);

ANTIBODIES, NEUTRALIZING; ANTIBODY FORMATION; BINDING SITES; HEK293 CELLS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; PROTEIN BINDING;

EID: 84975744755     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2015.11.063     Document Type: Article

References (36)

1. Bedford, T., Suchard, M.A., Lemey, P., Dudas, G., Gregory, V., Hay, A.J., McCauley, J.W., Russell, C.A., Smith, D.J., Rambaut, A., Integrating influenza antigenic dynamics with molecular evolution. eLife, 3, 2014, e01914.
2. Burton, D.R., Poignard, P., Stanfield, R.L., Wilson, I.A., Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses. Science 337 (2012), 183–186.
3. Corti, D., Lanzavecchia, A., Broadly neutralizing antiviral antibodies. Annu. Rev. Immunol. 31 (2013), 705–742.
4. Corti, D., Voss, J., Gamblin, S.J., Codoni, G., Macagno, A., Jarrossay, D., Vachieri, S.G., Pinna, D., Minola, A., Vanzetta, F., et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333 (2011), 850–856.
5. Davenport, F.M., Hennessy, A.V., Francis, T. Jr., Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus. J. Exp. Med. 98 (1953), 641–656.
6. De Silva, N.S., Klein, U., Dynamics of B cells in germinal centres. Nat. Rev. Immunol. 15 (2015), 137–148.
7. Ekiert, D.C., Bhabha, G., Elsliger, M.A., Friesen, R.H., Jongeneelen, M., Throsby, M., Goudsmit, J., Wilson, I.A., Antibody recognition of a highly conserved influenza virus epitope. Science 324 (2009), 246–251.
8. Fera, D., Schmidt, A.G., Haynes, B.F., Gao, F., Liao, H.X., Kepler, T.B., Harrison, S.C., Affinity maturation in an HIV broadly neutralizing B-cell lineage through reorientation of variable domains. Proc. Natl. Acad. Sci. USA 111 (2014), 10275–10280.
9. Fonville, J.M., Wilks, S.H., James, S.L., Fox, A., Ventresca, M., Aban, M., Xue, L., Jones, T.C., Le, N.M., Pham, Q.T., et al. Antibody landscapes after influenza virus infection or vaccination. Science 346 (2014), 996–1000.
10. Haynes, B.F., Kelsoe, G., Harrison, S.C., Kepler, T.B., B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study. Nat. Biotechnol. 30 (2012), 423–433.
11. Hensley, S.E., Challenges of selecting seasonal influenza vaccine strains for humans with diverse pre-exposure histories. Curr. Opin. Virol. 8 (2014), 85–89.
12. Hooper, L.V., Littman, D.R., Macpherson, A.J., Interactions between the microbiota and the immune system. Science 336 (2012), 1268–1273.
13. Huang, K.Y., Rijal, P., Schimanski, L., Powell, T.J., Lin, T.Y., McCauley, J.W., Daniels, R.S., Townsend, A.R., Focused antibody response to influenza linked to antigenic drift. J. Clin. Invest. 125 (2015), 2631–2645.
14. Jackson, K.J., Liu, Y., Roskin, K.M., Glanville, J., Hoh, R.A., Seo, K., Marshall, E.L., Gurley, T.C., Moody, M.A., Haynes, B.F., et al. Human responses to influenza vaccination show seroconversion signatures and convergent antibody rearrangements. Cell Host Microbe 16 (2014), 105–114.
15. Jardine, J.G., Ota, T., Sok, D., Pauthner, M., Kulp, D.W., Kalyuzhniy, O., Skog, P.D., Thinnes, T.C., Bhullar, D., Briney, B., et al. HIV-1 VACCINES. Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen. Science 349 (2015), 156–161.
16. Jensen, K.E., Davenport, F.M., Hennessy, A.V., Francis, T. Jr., Characterization of influenza antibodies by serum absorption. J. Exp. Med. 104 (1956), 199–209.
17. Kepler, T.B., Reconstructing a B-cell clonal lineage. I. Statistical inference of unobserved ancestors. F1000Res., 2, 2013, 103.
18. Kim, J.H., Skountzou, I., Compans, R., Jacob, J., Original antigenic sin responses to influenza viruses. J. Immunol. 183 (2009), 3294–3301.
19. Knossow, M., Gaudier, M., Douglas, A., Barrère, B., Bizebard, T., Barbey, C., Gigant, B., Skehel, J.J., Mechanism of neutralization of influenza virus infectivity by antibodies. Virology 302 (2002), 294–298.
20. Koel, B.F., Burke, D.F., Bestebroer, T.M., van der Vliet, S., Zondag, G.C., Vervaet, G., Skepner, E., Lewis, N.S., Spronken, M.I., Russell, C.A., et al. Substitutions near the receptor binding site determine major antigenic change during influenza virus evolution. Science 342 (2013), 976–979.
21. Krammer, F., Palese, P., Advances in the development of influenza virus vaccines. Nat. Rev. Drug Discov. 14 (2015), 167–182.
22. Li, G.M., Chiu, C., Wrammert, J., McCausland, M., Andrews, S.F., Zheng, N.Y., Lee, J.H., Huang, M., Qu, X., Edupuganti, S., et al. Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells. Proc. Natl. Acad. Sci. USA 109 (2012), 9047–9052.
23. Li, Y., Myers, J.L., Bostick, D.L., Sullivan, C.B., Madara, J., Linderman, S.L., Liu, Q., Carter, D.M., Wrammert, J., Esposito, S., et al. Immune history shapes specificity of pandemic H1N1 influenza antibody responses. J. Exp. Med. 210 (2013), 1493–1500.
24. Liao, H.X., Levesque, M.C., Nagel, A., Dixon, A., Zhang, R., Walter, E., Parks, R., Whitesides, J., Marshall, D.J., Hwang, K.K., et al. High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies. J. Virol. Methods 158 (2009), 171–179.
25. Liao, H.X., Lynch, R., Zhou, T., Gao, F., Alam, S.M., Boyd, S.D., Fire, A.Z., Roskin, K.M., Schramm, C.A., Zhang, Z., et al., NISC Comparative Sequencing Program. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus. Nature 496 (2013), 469–476.
26. Moody, M.A., Zhang, R., Walter, E.B., Woods, C.W., Ginsburg, G.S., McClain, M.T., Denny, T.N., Chen, X., Munshaw, S., Marshall, D.J., et al. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS ONE, 6, 2011, e25797.
27. Schmidt, A.G., Xu, H., Khan, A.R., O'Donnell, T., Khurana, S., King, L.R., Manischewitz, J., Golding, H., Suphaphiphat, P., Carfi, A., et al. Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody. Proc. Natl. Acad. Sci. USA 110 (2013), 264–269.
28. Schmidt, A.G., Therkelsen, M.D., Stewart, S., Kepler, T.B., Liao, H.X., Moody, M.A., Haynes, B.F., Harrison, S.C., Viral receptor-binding site antibodies with diverse germline origins. Cell 161 (2015), 1026–1034.
29. Smith, D.J., Lapedes, A.S., de Jong, J.C., Bestebroer, T.M., Rimmelzwaan, G.F., Osterhaus, A.D., Fouchier, R.A., Mapping the antigenic and genetic evolution of influenza virus. Science 305 (2004), 371–376.
30. Sui, J., Hwang, W.C., Perez, S., Wei, G., Aird, D., Chen, L.M., Santelli, E., Stec, B., Cadwell, G., Ali, M., et al. Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses. Nat. Struct. Mol. Biol. 16 (2009), 265–273.
31. Tan, Y.C., Blum, L.K., Kongpachith, S., Ju, C.H., Cai, X., Lindstrom, T.M., Sokolove, J., Robinson, W.H., High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination. Clin. Immunol. 151 (2014), 55–65.
32. Victora, G.D., Nussenzweig, M.C., Germinal centers. Annu. Rev. Immunol. 30 (2012), 429–457.
33. Weis, W., Brown, J.H., Cusack, S., Paulson, J.C., Skehel, J.J., Wiley, D.C., Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid. Nature 333 (1988), 426–431.
34. Whittle, J.R., Zhang, R., Khurana, S., King, L.R., Manischewitz, J., Golding, H., Dormitzer, P.R., Haynes, B.F., Walter, E.B., Moody, M.A., et al. Broadly neutralizing human antibody that recognizes the receptor-binding pocket of influenza virus hemagglutinin. Proc. Natl. Acad. Sci. USA 108 (2011), 14216–14221.
35. Wrammert, J., Koutsonanos, D., Li, G.M., Edupuganti, S., Sui, J., Morrissey, M., McCausland, M., Skountzou, I., Hornig, M., Lipkin, W.I., et al. Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection. J. Exp. Med. 208 (2011), 181–193.
36. Xu, H., Schmidt, A.G., O'Donnell, T., Therkelsen, M.D., Kepler, T.B., Moody, M.A., Haynes, B.F., Liao, H.X., Harrison, S.C., Shaw, D.E., Key mutations stabilize antigen-binding conformation during affinity maturation of a broadly neutralizing influenza antibody lineage. Proteins 83 (2015), 771–780.